Skip to main content
All stories

#Medical AI

12 articles on VentureBeast.Tech covering Medical AI. Strategic analysis and original reporting on medical ai for builders and operators.

12 articles tagged #Medical AI.

ChatGPT Health vs Apple Health: Who Gets Your Medical Data?
HealthTech12 min

ChatGPT Health vs Apple Health: Who Gets Your Medical Data?

ChatGPT Health is live for US adults; Apple's AI Health app is due later this year. Neither is HIPAA-covered. Custody of your data is the real divide.

Digital Pathology AI 2026: Paige, PathAI, Cancer Diagnosis
HealthTech9 min

Digital Pathology AI 2026: Paige, PathAI, Cancer Diagnosis

Roche is buying PathAI for up to $1.05B. Paige's AI raised prostate cancer detection sensitivity from 88.7% to 96.6%. Digital pathology just went mainstream.

BCIs Beyond Neuralink: Synchron, Precision Neuroscience
Emerging Tech10 min

BCIs Beyond Neuralink: Synchron, Precision Neuroscience

No BCI has full FDA approval yet. Synchron's safer endovascular approach and Precision Neuroscience's minimally invasive array may beat Neuralink there.

AI Drug Discovery 2026: Insilico, Isomorphic, Recursion
HealthTech10 min

AI Drug Discovery 2026: Insilico, Isomorphic, Recursion

Eli Lilly committed $4.5B+ to Insilico and Isomorphic Labs. 200+ AI-discovered drugs are in trials. Zero are FDA-approved yet. Here's the real scorecard.

AI Radiology 2026: FDA-Cleared Imaging Tools Explained
HealthTech10 min

AI Radiology 2026: FDA-Cleared Imaging Tools Explained

1,039 FDA-cleared AI radiology devices exist in 2026. Viz.ai's stroke triage has the strongest evidence; Aidoc just shipped the first foundation model.

Concussion Tech 2026: Helmets, Q-Collar, ImPACT Compared
SportsTech10 min

Concussion Tech 2026: Helmets, Q-Collar, ImPACT Compared

Three concussion-prevention layers — Riddell AXIOM helmets, the FDA-cleared Q-Collar, and ImPACT cognitive testing — compared head-to-head for 2026.

At-Home Genomics 2026: 23andMe, Nucleus, Genomelink
HealthTech10 min

At-Home Genomics 2026: 23andMe, Nucleus, Genomelink

23andMe restructured after Chapter 11. Nucleus pushes WGS upmarket. Genomelink wins on raw-data reanalysis. Pick your tier based on the actual use case.

GLP-1 Dispensing 2026: LillyDirect, Noom Med, Foundayo
HealthTech9 min

GLP-1 Dispensing 2026: LillyDirect, Noom Med, Foundayo

Eli Lilly's LillyDirect cash-pay platform and Foundayo oral GLP-1 launch bypassed insurers and PBMs. Noom Med partnered. Hims & Hers got squeezed.

Telehealth Shakeout: Hims, Ro, Lemonaid in 2026
HealthTech9 min

Telehealth Shakeout: Hims, Ro, Lemonaid in 2026

Hims & Hers hit $2.35B in 2025 — but the GLP-1 wave that drove growth triggered FDA, SEC, and Novo Nordisk legal exposure. The DTC market is consolidating.

Wearable ECG 2026: Apple, Withings, Samsung, Pixel Compared
HealthTech9 min

Wearable ECG 2026: Apple, Withings, Samsung, Pixel Compared

Four FDA-cleared wrist ECGs in 2026 — Apple Watch, Withings ScanWatch 2, Samsung Galaxy Watch, Pixel Watch. Accuracy ranges 84-98%. Here's how to pick.

AI Mental Health Chatbots: Wysa, Woebot, Replika in 2026
HealthTech9 min

AI Mental Health Chatbots: Wysa, Woebot, Replika in 2026

Wysa and Woebot have FDA Breakthrough designations and peer-reviewed RCTs. Replika is companion AI, not therapy. Don't conflate the two categories.

Ambient Clinical AI 2026: DAX, Abridge, Suki Compared
HealthTech9 min

Ambient Clinical AI 2026: DAX, Abridge, Suki Compared

DAX Copilot owns enterprise. Abridge wins outcomes-evidence at Kaiser and Mayo. Suki serves independents. The 2026 ambient-AI market is settled.